Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis

Patients with primary biliary cholangitis (PBC) with incomplete response to ursodeoxycholic acid are at risk of disease progression and need additional therapy. Obeticholic acid (OCA) was approved in Canada in May 2017, but its effectiveness in a real‐world setting has not been described. We sought...

全面介紹

Na minha lista:
書目詳細資料
發表在:Hepatol Commun
Main Authors: Roberts, Surain B., Ismail, Marwa, Kanagalingam, Gowthami, Mason, Andrew L., Swain, Mark G., Vincent, Catherine, Yoshida, Eric M., Tsien, Cynthia, Flemming, Jennifer A., Janssen, Harry L.A., Hirschfield, Gideon M., Hansen, Bettina E., Gulamhusein, Aliya F.
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2020
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471421/
https://ncbi.nlm.nih.gov/pubmed/32923836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1518
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍